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Abstract
Interferon regulatory factor 6 (IRF6) belongs to a family of nine transcription factors that share a
highly conserved helix–turn–helix DNA-binding domain and a less conserved protein-binding
domain. Most IRFs regulate the expression of interferon-α and -β after viral infection1, but the
function of IRF6 is unknown. The gene encoding IRF6 is located in the critical region for the Van
der Woude syndrome (VWS; OMIM 119300) locus at chromosome 1q32–q41 (refs 2,3). The
disorder is an autosomal dominant form of cleft lip and palate with lip pits4, and is the most
common syndromic form of cleft lip or palate. Popliteal pterygium syndrome (PPS; OMIM
119500) is a disorder with a similar orofacial phenotype that also includes skin and genital
anomalies5. Phenotypic overlap6 and linkage data7 suggest that these two disorders are allelic. We
found a nonsense mutation in IRF6 in the affected twin of a pair of monozygotic twins who were
discordant for VWS. Subsequently, we identified mutations in IRF6 in 45 additional unrelated
families affected with VWS and distinct mutations in 13 families affected with PPS. Expression
analyses showed high levels of Irf6 mRNA along the medial edge of the fusing palate, tooth buds,
hair follicles, genitalia and skin. Our observations demonstrate that haploinsufficiency of IRF6
disrupts orofacial development and are consistent with dominant-negative mutations disturbing
development of the skin and genitalia.
To identify the locus associated with VWS, we carried out direct sequence analysis of genes
and presumptive transcripts in the 350-kilobase (kb) critical region3. This approach is
confounded by single-nucleotide polymorphisms (SNPs), normal DNA sequence variation
that occurs about once every 1,900 base pairs8 (bp). To distinguish between putative
disease-causing mutations and SNPs, we studied a pair of monozygotic twins discordant for
the VWS phenotype and whose parents were unaffected. Monozygotic status was confirmed
by showing complete concordance of genotype at 20 microsatellite loci. We proposed that
the only sequence difference between the twins would result from a somatic mutation found
only in the affected twin. We identified a nonsense mutation in exon 4 of IRF6 in the
affected twin, which was absent in both parents and the unaffected twin (Fig. 1a). We
subsequently identified mutations in 45 additional unrelated families affected with VWS and
in 13 families affected with PPS (Fig. 1b; Table 1), demonstrating unequivocally that these
two syndromes are allelic6,7. These mutations were not observed in a minimum of 180
control chromosomes.
Clefts of the lip with or without cleft palate and isolated cleft palate are developmentally and
genetically distinct9, yet VWS is a single-gene disorder that encompasses both clefting
phenotypes. To verify this, we analyzed pedigrees (n = 22) that had a single mutation in
IRF6 and affected individuals with both phenotypes. Genotype analysis of family VWS25
demonstrated that affected individuals, regardless of their phenotype, shared the 18-bp
deletion found in the proband (Fig. 1a). We observed similar results in the other families and
conclude that a single mutation in IRF6 can cause both types of cleft.
To determine the effect of mutations on IRF6 gene activity, we compared the type and
position of the mutation with the phenotype. Previous identification of deletions
encompassing the VWS locus (including IRF6 in its entirety) had suggested that the
phenotype is caused by haploinsufficiency10–12. In this study, we found protein-truncation
(nonsense and frameshift) mutations in 22 families (Fig. 1b). Protein-truncation mutations
were significantly more common in VWS than in PPS (P = 0.004) and were consistent with
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haploinsufficiency in the VWS pedigrees. The lone exception to this relationship was a
nonsense mutation introducing a stop codon in place of a glutamine codon at position 393,
found in pedigree PPS11, which may be a dominant-negative mutation (see below).
The position of the missense mutations provides insight into the structure and function of the
IRF6 gene product. When we aligned the family of IRF proteins, we observed that IRF6 has
two conserved domains (Fig. 1b), a winged-helix DNA-binding domain (amino acids 13–
113) and a protein-binding domain (amino acids 226–394) termed SMIR (Smad-interferon
regulatory factor–binding domain)13. Studies of IRF3 and IRF7 have shown that the SMIR
domain is required to form homo- and heterodimers14,15. The dimers then translocate to the
nucleus, associate with other transcription factors and ultimately bind to their DNA
targets14. Of the missense mutations, 35 of 37 localized to regions encoding these two
domains. This distribution is non-random (P < 0.001), and we conclude that the domains are
critical for IRF6 function.
Whereas the missense mutations that cause VWS were almost evenly divided between the
two domains, most missense mutations that cause PPS were found in the DNA-binding
domain (11 of 13, Fig. 1b). This distribution is significant (P = 0.03) and suggests that
missense mutations in the DNA-binding domain associated with VWS and PPS affect IRF6
function differently. When we compared their positions with the crystal structure of the
IRF1 DNA-binding domain16, we found that every amino-acid residue that was mutant in
individuals with PPS directly contacts the DNA, whereas only one of seven of the residues
mutant in the individuals with VWS contacts the DNA. Most notably, we observed missense
mutations involving the same residue, Arg84, in seven unrelated PPS families (Fig. 1a,b).
The Arg84 residue is comparable to the Arg82 residue of IRF1. It is one of four residues that
make critical contacts with the core sequence, GAAA, and is essential for DNA binding16.
The observed change of this residue to a cysteine or histidine caused a complete loss of that
essential contact (Fig. 2). One possible explanation for this apparent genotype–phenotype
relationship is that missense mutations that cause VWS are due to a complete loss of
function of the mutated IRF6 protein, affecting both DNA and protein binding, whereas
missense mutations causing PPS affect only IRF6's ability to bind DNA. The ability of the
mutated IRF6 to bind to other proteins is unaffected, and it therefore forms inactive
transcription complexes; thus, this is a dominant-negative mutation. Similarly, deletion of
the DNA-binding domain of IRF3 or IRF7 exerts a dominant-negative effect on the virus-
induced expression of the type I interferon genes and the RANTES gene15,17.
To correlate the expression of IRF6 with the phenotypes of VWS and PPS, we carried out
RT–PCR, northern-blot analysis and whole-mount in situ hybridization. We found that Irf6
was broadly expressed in embryonic and adult mouse tissues (Fig. 3a,b), a pattern also seen
in human fetal and adult tissues (data not shown). Greater expression of Irf6 seemed to
occur in secondary palates dissected from day 14.5–15 mouse embryos and in adult skin.
Whole-mount in situ hybridization demonstrated that Irf6 transcripts were highly expressed
in the medial edges of the paired palatal shelves immediately before, and during, their fusion
(Fig. 3d). Similarly high Irf6 expression was seen in the hair follicles and palatal rugae (Fig.
3d), tooth germs and thyroglossal duct (Fig. 3f) and external genitalia (Fig. 3h), and in skin
throughout the body (data not shown). These observations are in accord with the VWS/PPS
phenotype: notably, 20% of individuals with VWS exhibit agenesis of the second premolar
teeth and 40% of individuals with PPS display genital anomalies.
Although we demonstrated that VWS and PPS are caused by mutations in a single gene, the
phenotype for any given mutation varied in at least three ways even within the same family.
Of the families with known mutations, we observed 32 families with multiple combinations
of orofacial anomalies, 22 families with mixed clefting phenotypes (individuals with cleft lip
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and individuals with cleft palate only in the same family) and four families affected with
PPS that included individuals who exhibit orofacial (VWS) features exclusively. The
marked phenotypic variation in our cohort strongly implicates the action of stochastic
factors or modifier genes on IRF6 function. In this context, we identified the sequence
variant Val274Ile (Fig. 1b). This variant occurs at an absolutely conserved residue within the
SMIR domain, is common in unaffected populations (3% in European-descended and 22%
in Asian populations) and is an attractive candidate for a modifier of VWS, PPS, and other
orofusial clefting disorders.
The mixed clefting phenotype is common in families affected with VWS, but very rare in
families with non-syndromic orofacial clefts, and is not seen in most other syndromic forms
of orofacial clefts. It is, however, also seen in clefting disorders caused by mutations in the
genes MSX1 (ref. 18) and TP63 (ref. 19,20), suggesting that these may be involved in a
common genetic pathway. In support of a common pathway, we found two IRF binding sites
in the promoter of MSX1 and one in the intron, all of which are conserved between human
mouse.
We are taking an integrated approach to dissecting the complex pathways that underlie
development of the lip and palate, including genetic analysis to identify the mutations that
cause orofacial clefts. The discordant monozygotic twins proved useful in this effort, and
provided proof of principle21 that discordant monozygotic pairs can be used to search for
modifiers or mutations, especially in regard to complex traits where mapping may be
imprecise and mutation analysis may be confounded by SNPs. We also used a large number
of samples from unrelated individuals to confirm that mutations in IRF6 are pathogenic for
both VWS and PPS and to prove that IRF6 is essential for development of the lip and palate
and is involved in development of the skin and external genitalia. The SMIR domain has
been proposed to mediate an interaction between IRFs and Smads13, a family of
transcription factors known to transduce TGF-β signals22. In addition, the expression of Irf6
along the medial edge of the palate seems to overlap with Tgfb3 (ref. 23), and Tgfb3, along
with other members of this super-family such as Tgfb2 and Inhba, is required for palatal
fusion24–27. Together with our data, these observations support a role for IRF6 in the
transforming growth factor-β (TGF-β) signaling pathway, a developmental pathway of
fundamental significance. The identification of IRF6 as a key determinant in orofacial
development will help us to further delineate and integrate the molecular pathways
underlying morphogenesis of the lip and palate.
Methods
Families
Families affected with VWS (n = 107) and PPS (n = 15) were identified and examined by
one or more geneticists or clinicians as previously described12. Nearly all families are of
northern European descent. Sample collection and inclusion criteria for VWS and PPS were
described previously3. We obtained written informed consent from all subjects and approval
for all protocols from the Institutional Review Boards at the University of Iowa and at the
University of Manchester.
Mutation analysis
We amplified exons 1–8 and part of exons 9 and 10 by standard PCR. The primer sequences
are available on request. The amplified products were purified (Qiagen) and directly
sequenced with an ABI Prism 3700. The sequence was analyzed using the computer
program PolyPhred.
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The IRF6 protein structure was predicted from its amino-acid sequence using Expasy, and
aligned with the known crystalline structure of the DNA-binding domain of IRF1 using the
UNIX-based computer software package Quanta (Accelrys). To model the mutations found
at position Arg84 in the IRF6 DNA-binding domain, the residue was manually altered to a
cysteine or a histidine. The package predicts all possible orientations of the altered side
chain and displays the position with the highest probability.
RT–PCR
We extracted total RNA using a standard guanidinium isothiocyanate, acid–phenol protocol.
RT–PCR analyses were performed and analyzed as detailed previously28 using a forward
primer designed in exon 4 and a reverse primer designed in exon 6 of Irf6. These primers
generate a single product of 212 bp from cDNA.
Northern-blot analysis
A multiple-tissue northern blot (Seegene) was hybridized with a probe generated by PCR
using primers derived from the distal end of the 3′ untranslated region of Irf6 and labeled as
recommended by the manufacturer with the StripE-Z system (Ambion). We hybridized the
blot in Express Hyb (Clontech), washed it as recommended and exposed it to X-ray film for
72 h at −80 °C.
Whole-mount in situ hybridization
Sense and anti-sense riboprobes were 1,600 bp in length, derived from the 3′ untranslated
region of Irf6 and generated with Sp6 and T7 promoters, respectively. We fixed embryos
dissected from time-mated MF1 mice in 4% paraformaldehyde overnight, processed them
and subjected them to hybridization with sense or anti-sense probes as described
previously29.
Statistical analysis
Statistical significance of mutation location was calculated with the Fisher's exact test using
the assumption of equal probability for a mutation at each residue.
URL
PolyPhred, http://droog.mbt.washington.edu/PolyPhred.html; Expasy, www.expasy.ch.
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Mutations in IRF6 cause VWS and PPS. a, Family number and mutation found for two
VWS pedigrees and one PPS pedigree. The gender of each individual was randomly
assigned to preserve the anonymity of the pedigrees; the actual pedigrees are available on
request. Unaffected individuals (open), probands (arrow) and individuals with VWS (blue)
or PPS (red) are indicated. Symbols representing specific phenotypes are shown below the
pedigree for family VWS25. The sequence chromatogram derived from the affected proband
is shown below the pedigrees for families VWS14 and PPS6. Above is an image of an
agarose gel that shows the restriction-fragment length polymorphism (RFLP) assay used to
confirm these mutations. Numbers on the side of each gel represent the size of the RFLP
products. The mutation in family VWS14 abolishes an EcoRI restriction site, whereas the
mutation in family PPS6 abolishes an HhaI site. Consequently, individuals with either
mutation exhibit the large undigested DNA fragment in addition to two smaller digested
products. Below the pedigree for VWS25 is an image of an agarose gel used to detect the
18-bp deletion mutation (132-bp fragment) or the wildtype allele (150-bp fragment). b, The
structure of the IRF6 gene. Exons (rectangles) are drawn to scale except for exon 9, which is
longer than shown. The brackets connecting the exons represent spliced introns, and the
break between exons 9 and 10 represents an unspliced intron of 1,621 nt that is present in
the most common 4.4-kb IRF6 transcript. The untranslated portions are in gray. The
predicted IRF6 protein contains a winged-helix DNA-binding domain (yellow) and a SMIR/
IAD protein-binding domain (green). The DNA-binding domain includes a pentatryptophan
(w) motif. The arrowheads indicate the relative position of protein-truncation (above exons)
and missense mutations (below exons) that cause VWS (blue) or PPS (red) or that are
polymorphisms (green). The arrow above exon 4 represents the Glu92X nonsense mutation
identified in the affected twin of family VWS14. The amino-acid change for each missense
mutation is shown and an asterisk indicates mutations affecting residues that contact the
DNA.
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Protein modeling of IRF6. The predicted IRF6 protein structure was aligned with the
crystalline structure of the DNA-binding domain of IRF1. In the wildtype protein (green),
the Arg84 residue (red) binds to the guanine (yellow) in the consensus sequence GAAA
(blue), found in the IFN-β promoter, by means of three interactions. A bidentate hydrogen
bond forms between two amine groups in the guanine base and the two amine groups in the
basic side chain of the arginine, measuring a distance of 2.6 Å. An electrostatic 2.2-Å salt
link also forms between the positively charged amine group of the arginine and the
negatively charged 5′ phosphate group that precedes the guanine base. In the Arg84Cys
mutant, the gap between the cysteine side chain and guanine base is greater than 3.10 Å, and
is thus too great to support a hydrogen bond. Cysteine cannot physically form hydrogen or
electrostatic bonds with the DNA, and this results in a disrupted DNA–protein interaction. In
the Arg84His mutant, the aromatic ring of the histidine side chain is predicted to be oriented
perpendicular to the DNA groove. This position would reduce the flexibility of the protein,
impeding its ability to hydrogen bond.
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Expression of mouse Irf6. a, RT–PCR analysis of mouse tissues. Irf6 is expressed
throughout a range of embryonic and adult tissues, although at low levels in brain, heart and
spleen. Greater Irf6 expression seems to occur in secondary palates dissected from day 14.5–
15 mouse embryos and in adult skin. PCR reactions carried out for 25 (not shown), 30
(shown) and 35 (not shown) cycles yielded similar results. Control RT–PCR experiments
were done using the ubiquitously expressed gene Tcof1 (ref. 28). b, Northern-blot analysis
of total RNA derived from whole mouse embryos at the day indicated. The Irf6 probe
detects a transcript of approximately 4 kb and a larger transcript (arrow) whose size could
not be determined. The amount of total RNA loaded into each lane was verified by ethidium
bromide staining of the 28S rRNA transcript. c–h, Whole-mount in situ hybridization of day
14.5 mouse embryos. High Irf6 expression is observed in the hair follicles (d, white arrow),
palatal rugae (d, black arrow), medial edge of the secondary palate immediately before and
during fusion (d, arrowhead), mandibular molar tooth germs (f, arrow), thyroglossal duct (f,
arrowhead) and penis (h). c,e,g, Embryos from the same litter hybridized with the sense
probe are presented for comparison.
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Table 1
IRF6 mutations
Family Mutation nt change aa change Exon
VWS1 frameshift A–48T 5′UTR to Met 2
VWS2 frameshift G3A Met1Ile 3
VWS3 missense C5T Ala2Val 3
VWS4 frameshift 17ins(C) Arg6fs 3
VWS35 frameshift 49del (CAGGTGGATAGTGGCC) Gln17fs 3
VWS5 missense G52A 3
VWS36 missense T53C 3
VWS37 nonsense C69A 3
VWS6 missense C115G 3
PPS1 missense T178G 4
VWS7 missense C182G 4
PPS2 missense A197C 4
VWS8 nonsense C202T 4
VWS9 nonsense C202T 4
VWS10 missense G208C 4
VWS11 missense G208C 4
VWS45 missense C226T 4
PPS13 missense C244A 4
PPS3 missense C250T 4
PPS4 missense C250T 4
PPS5 missense C250T 4
PPS6 missense C250T 4
PPS7 missense C250T 4
PPS8 missense G251A 4
PPS9 missense G251A 4
VWS12 missense A262C 4
PPS10 missense A265G 4
VWS13 missense A268G 4
VWS14 nonsense G274T 4
VWS41 nonsense G274T 4
VWS15 missense G292C 4
VWS16 nonsense C352T Gln118X 4
VWS17 frameshift 466ins(C) His156fs 5
VWS18 nonsense C558A Cys186X 6
VWS19 nonsense G576A Trp192X 6
VWS20 frameshift 634in(CCAC) Ser212fs 6
VWS21 frameshift 657del (CTCTCTCCC)ins(TA) Ser219fs 6
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Family Mutation nt change aa change Exon
VWS42 frameshift 744del(CTGCC) 7
VWS22 missense G749A 7
VWS43 nonsense T759A 7
VWS44 frameshift 795del(C) 7
VWS23 missense A818G 7
VWS24 frameshift 842del(A) 7
VWS25 deletion 870del (CACTAGCAAGCTGCTGGAC)ins(A) 7
VWS46 missense T881C 7
VWS26 missense G889A 7
VWS38 missense A958G 7
VWS39 missense A958G 7
VWS27 missense G961A 7
VWS40 missense G974A 7
VWS28 missense T1034C 7
VWS29 missense G1040T 7
VWS30 missense T1106C 8
VWS31 missense C1122G 8
VWS32 missense A1162G 8
PPS11 nonsense C1177T 8
VWS33 nonsense C1234T Arg412X 9
PPS12 missense G1288A Asp430Asn 9
VWS34 frameshift 1381ins(C) Pro461fs 9
Nucleotide position is relative to start codon. Mutations in the DNA-binding and SMIR/IAD domains are located in the top and bottom box,
respectively.
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